A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF). The alpha subunit of HIF is targeted for degradation under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF. We identified a conserved family of HIF prolyl hydoxylase (HPH) enzymes that appear to be responsible for this posttranslational modification. In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH. Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene ( LDH , encoding lactate dehydrogenase) under normoxic conditions. These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The two proline residues (P402/ P564) located in the LXXLAP amino acid motif in the ODDD of HIF-1α were found to be good substrates for the action of a group of enzymes called prolyl-4-hydroxylases (PHDs) or HIF-1 prolyl hydroxylases (HPH)22, 28.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [22]
In the citing paper
“Oxygen sensing is mediated primarily by prolyl hydroxylase domain-containing proteins (PHDs), iron- and ascorbate-dependent enzymes in the 2-oxoglutarate (2-OG)–dependent dioxygenase family”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“These enzymes are essential for repressing HIF signaling in an oxygen-dependent manner [42,43]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“Under normoxic conditions, prolyl hydroxylase enzymes (EGLN 1–3, also known as PHD 1–3) use oxygen as a substrate to hydroxylate key proline residues within the HIF-1 and HIF-2 α subunits”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
In the citing paper
“Hypoxia activates HIF signaling by promoting the protein stability of HIF-α subunits.”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Cited by
Items 701–800 of 1,022
Pawlus, M. R., & Hu, C.-J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.018 · Cited by 84
Timmins, A., Saint-André, M., & de Visser, S. P. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02839 · Cited by 100
Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer
Schito, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_5 · Cited by 100
Alderdice, R., Suggett, D. J., Cárdenas, A., Hughes, D. J., Kühl, M., Pernice, M., & Voolstra, C. R. (2020) · Global Change Biology · doi:10.1111/gcb.15436 · Cited by 101
“…transcribed via a series of signalling events by growth factors and kinases (receptor tyrosine kinase [RTK], phosphatidylinositol-4, 5-bisphosphate-3-kinase [PI3K], mitogen-activated protein kinases [MAPK] and mammalian target of rapamycin [mTOR]; Bruick & McKnight, 2001; Glück et al., 2015).”
BackgroundBeuck, S., Schänzer, W., & Thevis, M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.390 · Cited by 101
Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer
Li, Y., Zhang, D., Wang, X., Yao, X., Cheng, Y., Zhang, S., Wang, H., Chang, C., Xia, H., Wang, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12495 · Cited by 100
Hervouet, E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgi001 · Cited by 82
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1978-z · Cited by 99
“In 2001, Bruick and McKnight [107] and independently Epstein et al. [108] identified three genes encoding novel prolyl 4-hydroxy- lases (prolyl hydroxylase domain-containing proteins 1-3, PHD1-3), which hydroxylated two proline residues in HIF- 1a proteins provoking their degradation.”
BackgroundChen, R., Xu, M., Hogg, R. T., Li, J., Little, B. B., Gerard, R. D., & Garcia, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244780 · Cited by 99
“HIF- protein levels increase during hypoxia due to impaired modifications of two proline residues (5, 6) located in the NTAD/oxygen-dependent degradation domain (7), which are otherwise hydroxylated under normoxic conditions by oxygen-dependent prolyl hydroxylases (6, 8, 9) and thereby target the HIFproteins for von H…”
BackgroundHIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions
Lee, H.-Y., Choi, K., Oh, H., Park, Y.-K., & Park, H. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2250 · Cited by 87
Mueller, S., Millonig, G., & Waite, G. N. (2009) · Advances in Medical Sciences · doi:10.2478/v10039-009-0042-3 · Cited by 99
The Hypoxia-Inducible Factor and Tumor Progression Along the Angiogenic Pathway
Brahimi-Horn, M. C., & Pouysségur, J. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42004-x · Cited by 100
Oktay, Y., Dioum, E., Matsuzaki, S., Ding, K., Yan, L.-J., Haller, R. G., Szweda, L. I., & Garcia, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611133200 · Cited by 92
Myostatin Up-Regulation Is Associated with the Skeletal Muscle Response to Hypoxic Stimuli
Hayot, M., Rodriguez, J., Vernus, B., Carnac, G., Jean, E., Allen, D., Goret, L., Obert, P., Candau, R., & Bonnieu, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.008 · Cited by 98
“human myotubes with the cobalt chloride (CoCl2) which mimics hypoxia by inducing HIF-1 function (Bruick and McKnight, 2001; Wang et al., 1995).”
BackgroundMethodRehn, M., Olsson, A., Reckzeh, K., Diffner, E., Carmeliet, P., Landberg, G., & Cammenga, J. (2011) · Blood · doi:10.1182/blood-2011-01-332890 · Cited by 99
mTOR as a Positive Regulator of Tumor Cell Responses to Hypoxia
Abraham, R. T. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_18 · Cited by 98
Asikainen, T. M., Schneider, B. K., Waleh, N. S., Clyman, R. I., Ho, W.-B., Flippin, L. A., Günzler, V., & White, C. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504520102 · Cited by 90
Tan, S. C., Carr, C. A., Yeoh, K. K., Schofield, C. J., Davies, K. E., & Clarke, K. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1281-5 · Cited by 98
Filatova, A., Seidel, S., Böğürcü, N., Gräf, S., Garvalov, B. K., & Acker, T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2630 · Cited by 99
Regulation of Cellular Gas Exchange, Oxygen Sensing, and Metabolic Control
Clanton, T. L., Hogan, M. C., & Gladden, L. B. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120030 · Cited by 80
Oxygen, Epigenetics and Stem Cell Fate
Okazaki, K. M., & Maltepe, E. (2005) · Regenerative Medicine · doi:10.2217/17460751.1.1.71 · Cited by 99
Bras, A. L., Lionneton, F., Mattot, V., Lelièvre, E., Caëtano, B., Spruyt, N., & Soncin, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210566 · Cited by 98
“HIF-1a is a highly unstable protein that undergoes rapid degradation in normal oxygen levels, due to hydroxylation of two prolines (Ivan et al., 2001; Jaakkola et al., 2001) by the oxygen-dependent prolyl-4hydroxylases (Bruick and McKnight, 2001).”
BackgroundKimura, S., Kitadai, Y., Tanaka, S., Kuwai, T., Hihara, J., Yoshida, K., Toge, T., & Chayama, K. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.035 · Cited by 97
Keskiaho, K., Hieta, R., Sormunen, R., & Myllyharju, J. (2007) · The Plant Cell · doi:10.1105/tpc.106.042739 · Cited by 80
“The use of dioxygen by HIF prolyl hydroxylase (PHD1).”
BackgroundInfluentialKnowles, H. J., & Athanasou, N. (2008) · The Journal of Pathology · doi:10.1002/path.2319 · Cited by 96
Identification and function of hypoxia-response genes in Drosophila melanogaster
Liu, G., Roy, J., & Johnson, E. A. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00262.2005 · Cited by 96
Lee, H., Bien, C. M., Hughes, A. L., Espenshade, P. J., Kwon‐Chung, K. J., & Chang, Y. C. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05844.x · Cited by 83
“For instance, CoCl2 stabilizes HIF-1a subunits by preventing the binding of oxygen molecules to the HIF prolyl hydroxylases, and subsequent HIF-1a hydroxylation and degradation by the proteosome ( Bruick and McKnight, 2001; Jaakkola et al., 2001; Semenza, 2004).”
BackgroundHypoxia and Bone Metastatic Disease
Johnson, R. W., Sowder, M. E., & Giaccia, A. J. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0378-8 · Cited by 96
Targeting hypoxia tolerance in cancer
Wouters, B. G., van den Beucken, T., Magagnin, M. G., Lambin, P., & Koumenis, C. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2003.12.004 · Cited by 98
Akt and Hypoxia-Inducible Factor-1 Independently Enhance Tumor Growth and Angiogenesis
Arsham, A. M., Plas, D. R., Thompson, C. B., & Simon, M. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2239 · Cited by 88
Daijo, H., Hoshino, Y., Kai, S., Suzuki, K., Nishi, K., Matsuo, Y., Harada, H., & Hirota, K. (2016) · Scientific Reports · doi:10.1038/srep34424 · Cited by 95
A domain responsible for HIF-1α degradation by YC-1, a novel anticancer agent
Kim, H.-L., Yeo, E.-J., Chun, Y.-S., & Park, J.-W. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.255 · Cited by 79
Flashman, E., Bagg, E. A. L., Chowdhury, R., Mecinović, J., Loenarz, C., McDonough, M. A., Hewitson, K. S., & Schofield, C. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707411200 · Cited by 87
Knowles, H. J., Mole, D. R., Ratcliffe, P. J., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2351 · Cited by 94
“Under normoxic conditions, HIFa is posttranslationally hydroxylated by the prolyl hydroxylase domain enzymes (PHD1-3), targeting it for interaction with the von-Hippel Lindau (VHL) E3 ubiquitin ligase complex and rapid proteasomal degradation (2, 3).”
BackgroundInfluentialSong, Z., Zhou, W., Shu, R., & Ni, J. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00810.x · Cited by 94
Mitochondrial complex III: An essential component of universal oxygen sensing machinery?
Chandel, N. S. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.004 · Cited by 95
“This hydroxylation reaction is catalyzed by the prolyl hydroxylase domain 2 protein (PHD2) (Bruick and McKnight, 2001; Epstein et al., 2001; Huang et al., 2002).”
BackgroundTang, T. T.-L., & Lasky, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302042200 · Cited by 88
A Central Role for Hypoxic Signaling in Cartilage, Bone, and Hematopoiesis
Rankin, E. B., Giaccia, A. J., & Schipani, E. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0047-2 · Cited by 93
HIF-Prolyl Hydroxylases in the Rat Kidney
Schödel, J., Klanke, B., Weidemann, A., Buchholz, B., Bernhardt, W. M., Bertog, M., Amann, K., Korbmacher, C., Wiesener, M. S., Warnecke, C., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080687 · Cited by 93
Responding to Hypoxia: Lessons From a Model Cell Line
Seta, K. A., Spicer, Z., Yuan, Y., Lu, G., & Millhorn, D. E. (2002) · Science's STKE · doi:10.1126/stke.2002.146.re11 · Cited by 80
“Other investigators have also identified several human and mouse homologs (159-161).”
BackgroundFormenti, F., Beer, P. A., Croft, Q. P. P., Dorrington, K. L., Gale, D. P., Lappin, T. R. J., Lucas, G. S., Maher, E. R., Maxwell, P. H., McMullin, M. F., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-177378 · Cited by 92
Epigenomics and human adaptation to high altitude
Julian, C. G. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00351.2017 · Cited by 92
“Under normoxic conditions, prolylhydroxylases (PHDs), which are oxygen-dependent negative regulators of HIF, facilitate the hydroxylation of proline residues on the HIF1/2 subunits (17) which promotes the binding of von Hippel–Lindau tumor suppressor (vHL) protein and, subsequently, the proteasomal degradation of HIF1…”
BackgroundComparative Response of Brain to Chronic Hypoxia and Hyperoxia
Terraneo, L., & Samaja, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091914 · Cited by 92
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · PubMed · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 79
“HIF-1α further consists of three isoforms; HIF-1α, HIF- 2α, and HIF-3α and they all possessed an oxygendependent degradation domain (ODDD) which is important in mediating O2 regulation stability (Bruick and McKnight, 2001).”
BackgroundYang, R., Wang, J., Wang, F., Zhang, H., Tan, C., Chen, H., & Wang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032852 · Cited by 92
EGLN3 Prolyl Hydroxylase Regulates Skeletal Muscle Differentiation and Myogenin Protein Stability
Fu, J., Menzies, K. E., Freeman, R. S., & Taubman, M. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608748200 · Cited by 92
Xu, N., Liu, H., Qu, F., Fan, J., Mao, K., Yin, Y., Liu, J., Geng, Z., & Wang, Y. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.08.003 · Cited by 92
Epigenetics: New Questions on the Response to Hypoxia
Perez-Perri, J. I., Acevedo, J. M., & Wappner, P. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12074705 · Cited by 93
Rare insights into cancer biology
Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 93
Drosophila Cyclin D/Cdk4 Requires Hif-1 Prolyl Hydroxylase to Drive Cell Growth
Frei, C., & Edgar, B. A. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00409-x · Cited by 92
Stem cell factor induces HIF-1α at normoxia in hematopoietic cells
Pedersen, M., Löfstedt, T., Sun, J., Mengelbier, L. H., Påhlman, S., & Rönnstrand, L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.102 · Cited by 91
Physical Exercise and Epigenetic Modulation: Elucidating Intricate Mechanisms
Pareja-Galeano, H., Sanchis‐Gomar, F., & García‐Giménez, J. L. (2014) · Sports Medicine · doi:10.1007/s40279-013-0138-6 · Cited by 91
Laurenti, G., & Tennant, D. A. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160099 · Cited by 91
“ligase, which mediates ubiquitylation of the hydroxylated protein, permitting proteasomal degradation [27].”
BackgroundBell, E. L., & Chandel, N. S. (2007) · Essays in Biochemistry · doi:10.1042/bse0430017 · Cited by 90
Li, M.-H., Miao, Z.-H., Tan, W.-F., Yue, J.-M., Zhang, C., Lin, L.-P., Zhang, X.-W., & Ding, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0951 · Cited by 85
Inhibition of Prolyl Hydroxylase Domain Proteins Promotes Therapeutic Revascularization
Loinard, C., Ginouvès, A., Vilar, J., Cochain, C., Zouggari, Y., Recalde, A., Duriez, M., Lévy, B. I., Pouysségur, J., Berra, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.813303 · Cited by 82
Yadav, A. K., Yadav, P. K., Chaudhary, G. R., Tiwari, M., Gupta, A., Sharma, A., Pandey, A. N., Pandey, A. K., & Chaube, S. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03122-4 · Cited by 90
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Shi, Y., & Gilkes, D. M. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05537-0 · Cited by 90
Koslowski, M., Luxemburger, U., Türeci, Ö., & Şahin, U. (2010) · Oncogene · doi:10.1038/onc.2010.481 · Cited by 90
Yu, X., Fang, Y., Liu, H., Zhu, J., Zou, J., Xu, X., Jiang, S., & Ding, X. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr754 · Cited by 83
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
Heximer, S. P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318099c · Cited by 73
Von Hippel-Lindau disease and endocrine tumour susceptibility
Woodward, E. R., & Maher, E. R. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.00683 · Cited by 87
“In humans, three EGLN homologues have been implicated in HIF-a modification (PHD1/EglN2/HIFPH1, PHD2/EglN1/HIFPH2 and PHD3/EglN3/HIFPH3) (Bruick & McKnight 2001, Epstein et al. 2001). pVHL has also been implicated in a variety of cellular processes including regulation of angiogenic factors and apoptosis, mRNA stabili…”
BackgroundInfluentialOrtmann, B. M., Burrows, N., Lobb, I. T., Arnaiz, E., Wit, N., Bailey, P. S. J., Jordon, L., Lombardi, O., Peñalver, A., McCaffrey, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00887-y · Cited by 89
Tracheal remodelling in response to hypoxia
Centanin, L., Gorr, T. A., & Wappner, P. (2009) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2009.05.008 · Cited by 89
“…activity of HIF-a factors depends on the action of oxygen-dependent prolyl hydroxylases, known as PHDs (‘‘Prolyl Hydroxylase Domain’’ containing polypetides) (Bruick and McKnight, 2001; Epstein et al., 2001), and an asparaginyl hydroxylase (FIH-1) (Lando et al., 2002, 2003), respectively.”
Belanger, A. J., Luo, Z., Vincent, K. A., Akita, G. Y., Cheng, S. H., Gregory, R. J., & Jiang, C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.062 · Cited by 90
Haase, V. H. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.006 · Cited by 90
Shen, C., Shao, Z., & Powell-Coffman, J. A. (2006) · Genetics · doi:10.1534/genetics.106.063594 · Cited by 79
The VHL protein recruits a novel KRAB‐A domain protein to repress HIF‐1α transcriptional activity
Li, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg173 · Cited by 89
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Seebacher, N. A., Krchniaková, M., Stacy, A. E., Skoda, J., & Jansson, P. J. (2021) · Antioxidants · doi:10.3390/antiox10111801 · Cited by 89
Hopfer, U., Hopfer, H., Jablonski, K., Stahl, R. A. K., & Wolf, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513751200 · Cited by 88
HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression
Tennant, D. A., & Gottlieb, E. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0627-0 · Cited by 88
“HIFα subunits are labile under normoxic conditions due to the actions of PHD enzymes [ 9 ].”
BackgroundTargeting Protein–Protein Interactions in the HIF System
Wilkins, S. E., Abboud, M. I., Hancock, R. L., & Schofield, C. J. (2016) · ChemMedChem · doi:10.1002/cmdc.201600012 · Cited by 89
Cell-Autonomous Metabolic Reprogramming in Hypoxia
Schito, L., & Rey, S. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.006 · Cited by 89
Janji, B., Berchem, G., & Chouaïb, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00887 · Cited by 88
“Three prolyl hydroxylase domain (PHD) enzymes (PHD-1, PHD-2, and PHD-3) regulating HIF-1α proteasomal degradation have been identified (25, 26).”
BackgroundBouhamida, E., Morciano, G., Perrone, M., Kahsay, A. E., Della Sala, M., Wieckowski, M. R., Fiorica, F., Pinton, P., Giorgi, C., & Patergnani, S. (2022) · Biology · doi:10.3390/biology11020300 · Cited by 87
“Because of this, during normoxia HIF-1α protein has a short half-life [24,25].”
BackgroundRNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation
Hänze, J., Eul, B. G., Savai, R., Krick, S., Goyal, P., Grimminger, F., Seeger, W., & Rose, F. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.153 · Cited by 87
Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
Cai, Q., Verma, S. C., Kumar, P., Ma, M., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009720 · Cited by 76
“which requires the recognition of von Hippel Lindau (VHL) tumor suppressor [4–6].”
BackgroundHypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
Otrock, Z. K., Hatoum, H. A., Awada, A. H., Ishak, R. S., & Shamseddine, A. I. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.001 · Cited by 87
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
Pollard, P. J., Yang, M., Su, H., Soga, T., & Kranc, K. R. (2014) · Hypoxia · doi:10.2147/hp.s47968 · Cited by 87
“but not in their N-termini, the function of which remains to be elucidated.(8) There are three HIFα isoforms (HIF1α, HIF2α, and HIF3α).”
BackgroundBordoli, M. R., Stiehl, D. P., Borsig, L., Kristiansen, G., Hausladen, S., Schraml, P., Wenger, R. H., & Camenisch, G. (2010) · Oncogene · doi:10.1038/onc.2010.433 · Cited by 88
“Prolyl-4-hydroxylation is necessary for the interaction with the von HippelLindau tumor suppressor protein (pVHL) that mediates HIFα degradation (Bruick and McKnight, 2001; Epstein et al., 2001; Ivan et al., 2002; Jaakkola et al., 2001; Maxwell et al., 1999).”
Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis
Roh, S., Kasembeli, M. M., Bakthavatsalam, D., Chiu, W., & Tweardy, D. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125975 · Cited by 88
“In addition to VHL, immunoprecipitation and mass spectrometry studies indicate that prolyl hydroxylase domain 3 (PHD3) is a substrate of TRiC [81].”
BackgroundInfluentialOxygen Sensing in Retinal Health and Disease
Lange, C. A. K., & Bainbridge, J. W. B. (2012) · Ophthalmologica · doi:10.1159/000331418 · Cited by 86
Oxygen‐sensing mechanisms in cells
Wilson, J. W., Shakir, D., Batie, M., Frost, M., & Rocha, S. (2020) · The FEBS Journal · doi:10.1111/febs.15374 · Cited by 86
New Insights into the Role of Oxidative Stress in Scleroderma Fibrosis
Gabrielli, A., Svegliati, S., Moroncini, G., & Amico, D. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010087 · Cited by 87
“Under normal oxygen conditions, HIF-1 is hydroxylated by a prolyl hydroxylase and degraded upon binding of the von HippelLindau protein, the protein Elongin C and by recruitment of an E3 ubiquitin-protein ligase [23].”
BackgroundMitochondrial Regulation of Cell Survival and Death During Low-Oxygen Conditions
Snyder, C. M., & Chandel, N. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2730 · Cited by 81
“A family of proline hydroxylation enzymes, termed PHDs, catalyze this reaction (4, 27).”
Zhong, Z., Ramshesh, V. K., Rehman, H., Currin, R. T., Sridharan, V., Theruvath, T. P., Kim, I., Wright, G. L., & Lemasters, J. J. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90287.2008 · Cited by 84
“Recently, a family of oxygen-dependent PHDs has been identified as a cellular oxygen-sensing mechanism (4).”
BackgroundGuglielmotto, M., Tamagno, E., & Danni, O. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.93 · Cited by 82
“These most likely involve the PHDs, the oxidases involved in the post-translational modification that signals HIF-1α for degradation[71,72].”
BackgroundWang, Z., Schley, G., Turkoglu, G., Burzlaff, N. I., Amann, K., Willam, C., Eckardt, K., & Bernhardt, W. M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr379 · Cited by 86
Anoxia and glucose supplementation preserve neutrophil viability and function
Monceaux, V., Chiche-Lapierre, C., Chaput, C., Witko-Sarsat, V., Prevost, M.-C., Taylor, C. T., Ungeheuer, M.-N., Sansonetti, P. J., & Marteyn, B. S. (2016) · Blood · doi:10.1182/blood-2015-11-680918 · Cited by 77
“HIF-1a subunit abundance decreases under normoxic conditions because of hydroxylation by prolyl hydroxylases and subsequent targeting to proteasomal degradation.(11,12) Prolyl hydroxylase 3 was shown to be essential for HIF-1a degradation in neutrophils(13) and was inhibited by the pan-hydroxylase inhibitor dimethylox…”
Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase
Golias, T., Kery, M., Radenkovic, S., & Papandreou, I. (2018) · International Journal of Cancer · doi:10.1002/ijc.31812 · Cited by 86
“use oxygen as substrate, catalyzes these reactions.(3) Hydroxylated HIF-1α is recognized by the tumor suppressor pVHL which acts as an E3 ubiquitin ligase and targets HIF-1α for degradation by the proteasome.”
BackgroundMolecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 86
Vitamin C is dispensable for oxygen sensing in vivo
Nytko, K. J., Maeda, N., Schläfli, P., Spielmann, P., Wenger, R. H., & Stiehl, D. P. (2011) · Blood · doi:10.1182/blood-2010-09-307637 · Cited by 75
Koski, M. K., Hieta, R., Hirsilä, M., Rönkä, A. R., Myllyharju, J., & Wierenga, R. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014050 · Cited by 85
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 82
“termed PHD1, 2, and 3 (13, 30), and one asparaginyl hydroxylase responsible for modifying the CAD, named FIH (76).”
Milošević, J., Adler, I., Manaenko, A., Schwarz, S. C., Walkinshaw, G., Arend, M., Flippin, L. A., Storch, A., & Schwarz, J. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9043-z · Cited by 85
“Binding of the pVHL tumour suppressor protein requires the modification of HIF-1a by prolyl-4-hydroxylation at proline residues by the prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins ( Bruick and McKnight 2001; Ivan et al. 2001; Jaakkola 2001).”
BackgroundBeck, H., Jeske, M., Thede, K., Stoll, F., Flamme, I., Akbaba, M., Ergüden, J., Karig, G., Keldenich, J., Oehme, F., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201700783 · Cited by 85
Calzada, M. J., Esteban, M. A., Feijoo-Cuaresma, M., Castellanos, M. C., Naranjo-Suárez, S., Temes, E., Méndez, F., Yánez-Mo, M., Ohh, M., & Landázuri, M. O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3236 · Cited by 74
Linke, S., Stojkoski, C., Kewley, R. J., Booker, G. W., Whitelaw, M. L., & Peet, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313614200 · Cited by 77
Imidazole Ring-Opened DNA Purines and Their Biological Significance
Tudek, B. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.012 · Cited by 87
Chintala, S., Najrana, T., Toth, K., Cao, S., Durrani, F. A., Pili, R., & Rustum, Y. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-293 · Cited by 79
“Under regular oxygen conditions, HIF-1α is hydroxylated at proline 402 and proline 564 molecules by prolyl hydroxylases 2 and 3 (PHD2/3) which is then recognized by VHL and further degraded by proteasome [7,8].”
Background
Metadata
- Authors
- Bruick, R. K., & McKnight, S. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- McKnight, Steven L.
- ORCID
- McKnight, Steven L.
- Venue
- Science
- Published
- 2001-11-09
- Volume
- 294
- Issue
- 5545
- Pages
- 1337-1340
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2042216712
- Cited by
- 2,549
- References
- 27
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 67 · 2023: 65 · 2022: 90 · 2021: 95 · 2020: 80 · 2019: 90 · 2018: 103 · 2017: 98 · 2016: 113 · 2015: 109 · 2014: 104 · 2013: 115 · 2012: 114
- FWCI
- 42.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- prolyl 4-hydroxylase, hypoxia-inducible factor, HIF-1α, oxygen sensing, proline hydroxylation, protein degradation, ubiquitin ligase, post-translational modification, lactate dehydrogenase, Drosophila melanogaster, normoxia
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Drosophila melanogaster, Humans, Hydroxylation, Hydroxyproline, L-Lactate Dehydrogenase, Molecular Sequence Data, Mutation, Nuclear Proteins, Oxygen, Procollagen-Proline Dioxygenase, Recombinant Proteins, RNA, Double-Stranded, Substrate Specificity, Transcription Factors, Transfection, Cell Hypoxia, Gene Expression Regulation, Enzymologic, Sequence Alignment, Conserved Sequence, Genes, Insect, Genes, Reporter, Amino Acid Substitution, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.